Browse by People

Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 3.

King, J, Palmer, DH ORCID: 0000-0002-7147-5703, Johnson, P ORCID: 0000-0003-1404-0209, Ross, P, Hubner, RA, Sumpter, K, Darby, S, Braconi, C, Iwuji, C, Swinson, D
et al (show 8 more authors) (2017) Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK Audit. Clinical oncology (Royal College of Radiologists (Great Britain)), 29 (4). pp. 256-262.

Edeline, J, Blanc, J-F, Johnson, P ORCID: 0000-0003-1404-0209, Campillo-Gimenez, B, Ross, P, Ma, YT, King, J, Hubner, RA, Sumpter, K, Darby, S
et al (show 8 more authors) (2016) A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma. Liver international : official journal of the International Association for the Study of the Liver, 36 (12). pp. 1821-1828.

Palmer, DH ORCID: 0000-0002-7147-5703, Ma, YT, Peck-Radosavljevic, M, Ross, P, Graham, J, Fartoux, L, Deptala, A, Studeny, M, Schnell, D, Hocke, J
et al (show 2 more authors) (2018) A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma. British Journal of Cancer, 118 (9). pp. 1162-1168.

This list was generated on Thu Sep 28 22:03:57 2023 BST.